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Abstract 
Two new tricyclic β-aminoacrylate derivatives (2e and 3e) have been found to be inhibitors of 
Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) with Ki 0.037 and 0.15 μM 
respectively. 1H and 13C NMR spectroscopic data show that these compounds undergo ready cis-trans 
isomerisation at room temperature in polar solvents. In silico docking studies indicate that for both 
molecules there is neither conformation nor double bond configuration which bind preferentially to 
PfDHODH. This flexibility is favourable for inhibitors of this channel that require extensive 
positioning to reach their binding site. 
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 Malaria is one of the main infectious diseases in the world with an estimated 212 million cases 
in 2015, centred to a great extent on the countries in central Africa and south east Asia.1 The numbers 
are even starker when one considers it is estimated these cases led to an estimated 429,000 deaths and 
that approximately 70% of these deaths were of children under five years old. Malaria is considered a 
‘preventable’ disease, largely because of the use of chemotherapeutic agents,2 however widespread 
drug resistance3 has rendered these agents ineffective in many regions of the world. This problem has 
led to much effort being expended into validating novel drug targets, as well as discovering small 
molecule enzyme inhibitors to act as leads for development of new antimalarial drugs.4 One such target 
which has attracted recent attention is P. falciparum dihydroorotate dehydrogenase (PfDHODH),5 a 
key enzyme in the obligate de novo pyrimidine pathway for uridine monophosphate (UMP) 
biosynthesis. Early work aimed towards the discovery of PfDHODH inhibitors focussed on 
modification of the human DHODH (hDHODH) inhibitors known at the time, such as brequinar 
(Figure 1).6 This work was naturally followed by high throughput screening7 and de novo design 
approaches.8 During the progress of this work, co-crystallisation9 and in silico docking8,10 experiments 
revealed that the inhibitors discovered targeted the ubiquinone binding channel, and also revealed 
important features for the design of selective and potent inhibitors. Firstly amino acid residues H185 
and / or R265, at the head of the ubiquinone-binding channel, were found to be essential for hydrogen 
bonding interactions with the inhibitors. The ubiquinone channel also contained a hydrophobic region 
which contributes to the binding of the more potent inhibitors reported. Indeed many of the inhibitors 
reported to date6-12 reveal broadly this amphiphilic nature, and possess a polar ‘head group’ and 
hydrophobic ‘tail’. Triazolopyrimidine DSM265 (Figure 1) is currently the most advanced 
PfalDHODH inhibitor, and Phase 1 clinical trials for this candidate have recently been reported.13  
 We have reported previously that β-aminoacrylate derivatives of the general structure 1 (Figure 1) 
are inhibitors of PfDHODH.10 In particular, tricyclic derivatives 2a and 3b displayed sub-micromolar 
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IC50 values against PfDHODH, and in the case of 2a there was a 1000-fold greater potency compared 
to the human enzyme (hDHODH). An extensive series of experiments in this previous work with this 
class of inhibitors10a showed that compounds 2a and 3b, and related structures, were competitive 
inhibitors with the enzyme cofactor CoQ and reversible. Compounds such as 2a may in principle exist 
as a pair of geometric isomers and we considered that different H-bonding groups on either side of the 
double bond, and their position relative to the aromatic portion of the structure through rotation about 
the CAr-N bond, would be key in determining their binding to the enzyme. It is perhaps noteworthy to 
mention that alternative binding modes have been reported with certain hDHODH inhibitors,14 and 
also differential binding modes for A77 1726, the active metabolite of leflunomide (Figure 1), when 
binding to PfDHODH is compared to its principal target hDHODH.9a We therefore sought to examine 
whether alterative polar ‘head groups’ to those investigated would lead to improved activity of 
members in this class of compound, and the results obtained are reported herein.  
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Figure 1. Example structures of known PfalDHODH (brequinar, DSM265, 2a and 3b) and hDHODH 
(A77 1726) inhibitors. 
 
Ten new derivatives (2b-f, 3a,c-f) based on the 3-aminocarbazole (4) and 3-
aminodibenzothiophene (5) core unit were synthesised using the method reported previously (Scheme 
1).10a Derivatives 2b and 3a were prepared by simply heating the aromatic amine with the appropriate 
commercially available β-ethoxy-α,β-unsaturated carbonyl compound  6b and 6a respectively. For 2c-
f and 3c-f the relevant active methylene compounds 7c-f were first heated with an excess of 
triethylorthoformate (or acetate) in toluene, forming the β-ethoxy-α,β-unsaturated carbonyl 
compounds 6c-f in situ, followed by addition of either the aromatic amine 4 or 5 and heating for a 
further short period. After cooling, the products precipitated upon standing, were collected by filtration 
and then recrystallised.15  
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Scheme 1. Synthesis of β-aminoacrylate derivatives of 9-ethyl-3-aminocarbazole and 3-
aminodibenzothiophene in this study. 
 
Table 1 shows the IC50 values obtained for the compounds discussed in this work. These values were 
obtained using the screening methodology reported previously.10a The IC50 values of derivatives 2c,d,f 
and 3c,d,f were above the arbitrary cut-off value of 0.1 mM and thus not further examined. Derivatives 
2d and 3d, structures based upon Meldrum’s acid, are conformationally restricted analogues. We 
assigned their low activity to the restricted freedom imposed by the six-membered ring to position the 
polar head group for maximal hydrogen bonding to H-bond donors on either side the co-factor channel. 
 
Entry  PfalDHODH 
 IC50 (μM) 
hDHODH 
 IC50 (μM) 
2a 
0.28 ± 0.05 
0.44 ±0.06 10a 
 
491 ± 42 10a 
3a 1.2 n.d. 
2b 4.4 n.d. 
3b 
0.16 ± 0.05 
0.16 ± 0.05 10a 
 
30 ± 5.9 10a 
2c >100 n.d. 
3c >100 n.d. 
2d >100 n.d. 
3d >100 n.d. 
2e  0.094 ± 0.031 † >100 
3e  0.38 ± 0.06 ‡ >100 
2f >100 n.d. 
3f >100 n.d. 
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Table 1. IC50 values of selected compounds against P. falciparum and human DHODH. The IC50 
values were determined according to methodology reported previously.10a n.d. = not determined; † Ki 
vs PfalDHODH) for 2e was 0.037±0.012 μM; ‡ Ki (PfalDHODH) for 3e was 0.150±0.001 μM (cf. Ki 
= 0.05 and 0.02 μM for 2a and 3b respectively10a) 
 
 
 The activity of the cyanoacetate (2a, 3a) and malonate derivatives (2b, 3b) are not too dissimilar, 
and the IC50 values are probably subtly altered depending on the influence of the second ethyl ester 
and/or N-ethyl group. The lowest activity is seen with 2b, where both ethyl groups are present, may 
mean that the molecule is slightly too large to fit well into the ubiquinone binding site. Similarly, 
derivatives 2f and 3f, which only differ from 2a and 3a by a single methyl group, showed that 
substitution at this position cannot be tolerated sterically. The lack of activity in 2c and 3c was 
somewhat surprising, given the similar electron withdrawing effect of the methyl ketone compared to 
the ethyl ester and cannot so easily be explained.  
Nitroacrylate derivatives 2e and 3e were as active, if not more so, than cyanoacrylate and 
malonate derivatives 2a,b and 3a,b. As discussed above, we considered that the conformational 
preferences in the polar ‘head group’ would be important in determining the binding mode of these 
inhibitors to DHODH, and so it was interesting in particular to compare the isomerism in carbazole 
derivatives 2a, 2e and 2f, and the corresponding analogues of the dibenzothiophene series 3a, 3e and 
3f. In the case of 2a and 3a, evidence of only one isomer is seen in the 1H NMR. The heavily deshielded 
NH (δ 10.96 ppm for 2a and 11.26 ppm for 3a) and large coupling to the -CH= (J 13.7 Hz) indicated 
the presence of intramolecular hydrogen bonding to the ester carbonyl group, and the anti- 
displacement of the hydrogen atoms in the Ar-NH-CH= unit showed that the (Z)-isomer was preferred. 
In the case of 2f and 3f analysis of the products similarly revealed single isomers [δNH 11.56 (s) for 2f, 
and δNH 11.65 (s) for 3f] in spite of the extra methyl group (R3). The nitroacrylate derivatives 2e and 
3e have the possibility to exhibit intramolecular hydrogen bonding in either isomeric form, and the 
balance between these isomeric forms was expected to have an important effect on the overall isomeric 
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preferences and therefore binding to the cofactor channel of DHODH. The 1H NMR of both 2e and 3e 
showed a 1:1 mixture (in CDCl3) however many times it was recrystallised under a range conditions 
(solvent, rate of cooling etc), indicating no clear preference in solution for one isomer over the other.16 
The 13C NMR of 2e in CDCl3 showed doubling of almost all signals. However for 3e in the more polar 
d6-DMSO only one set of the aromatic carbon signals and ethyl group were observed, and also the 
signals for the acrylate unit were completely absent. This was accompanied by changes in the 1H NMR 
where in d6-DMSO the NH-CH= signals were broadened significantly and almost reduced to baseline 
level, and the ethyl CH2 quartet was greatly broadened. This indicates clearly that the geometric forms 
of 3e are readily interconvertible in a polar solvent on the NMR timescale. 
Carbazole 2e could be recrystallised from ethyl acetate to provide bright red crystals suitable for 
single crystal X-ray diffraction (see Supplementary Information).17 The first crop showed 2e had 
crystallised preferentially as the (Z)-isomer (Figure 2A). Examining the single crystal X-ray data of 2e 
it was interesting to find that the N2-C15 bond was much shorter than the C15-C16 bond and C9-N2 
bonds [1.3201(17) Å vs. 1.3914(18) Å vs. 1.4242(17) Å respectively]. These data are consistent with 
extensive delocalisation of the nitrogen lone pair into the enamine unit in the (Z)-isomer (Figure 2B), 
and could explain its deep red colour. After evaporation of the mother liquors and another 
recrystallization, the quality of the red crystals diminished and an orange powder was obtained upon 
evaporation of the mother liquors. Optical microscopy of this material showed two microcrystalline 
forms, one red and one orange, with the latter in large excess. We surmised the orange material may 
be the more soluble (E)-isomer. A portion of the orange powder was examined by X-ray powder 
diffraction using a PANAlytical Empyrean diffractometer operating with Cu Kα1 radiation. It was 
shown to be highly crystalline, but the diffraction pattern of the orange powder did not match that 
calculated from the structure of the red crystals obtained (Supplementary Information Figure S1). It 
was possible to index the powder diffraction pattern of the orange powder using a large triclinic cell. 
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The volume of this cell (2506 Å3) is approximately three times that of the cell found for the red crystals. 
It seems likely that the bulk of the orange sample contains the (E) isomer of 2e, and the tripling of the 
volume suggests that there are three molecules in the asymmetric unit, perhaps two of one isomeric 
form and one of the other.  Importantly, 1H NMR of either the red or orange crystalline forms showed, 
in CDCl3 solution, the same 1:1 mixture of the two geometric isomers.  
We were able to select a small single crystal of the orange material from among the original red 
crystals. The small crystal only diffracted weakly but we were able to obtain a crystal structure, albeit 
of lower quality than that of the red form.18 The structure is not too dissimilar to that of the red crystals, 
however it had a different orientation of both the N-ethyl and ethyl ester groups (Supplementary 
Information Figure S2). It also showed that the nitro group was not co-planar with the NH, as in the 
red crystals, but was inclined at an angle of 25(1) °. The crystal structure of this orange single crystal 
did not, however, match the powder diffraction pattern of the bulk orange material (Supplementary 
Information Figure S3). 
  















Figure 2A: Crystal structure of 2e with atoms drawn as 50% thermal ellipsoids The more crystalline 
form of 2e reveals a shortened N2-C15 bond, lengthened C15-C16 bond and an intermolecular 
hydrogen bond between the nitro group and the NH. Figure 2B: The bond lengths from the crystal 
structure of the deep red coloured 2e is consistent with large degree of delocalisation of the nitrogen 
lone pair.  
 
In order to probe the details of the interaction of these inhibitors with PfDHODH, docking 
(with both eHiTS and Autodock) of the E- and Z-forms of 2e and 3e into the putative ubiquinione 
binding channel of PfDHODH was performed using the PfDHODH crystal structure (PDB code; 
1TV5). The data produced suggest several possibilities for the binding of each isomer of 2e and 3e 
into PfDHODH. However all of the suggested poses are predicted to bind in the same general space 
of the enzyme, with the aromatic ‘tail’ group of each ligand binding deep within the large hydrophobic 
pocket of the binding site (Figures 3A and 3B). For each of the four structures (i.e. both E- and Z- 
isomers of both 2e and 3e) two equally favourable rotamers were observed with the tail group seen to 
adopt the orientations shown in Figures 3A and 3B.  
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   A      B 
Figure 3. Docking studies reveal that the hydrophobic aromatic tail group of 3e (forest green) and 2e 
(latter not shown) may adopt one of two equally preferred conformations (3A and 3B, rotated 180° 
around the Ar-NH bond) when docked into the ubiquinone co-factor channel of PfDHODH. In both 
cases hydrogen bonding networks with Tyr528, His185 and Arg265 are maintained. 
 
 
   
                                        A                                                                   B  
Figure 4. Docking studies reveal that the hydrophilic head group of 2e and 3e (latter not shown) 
may bind in two equally preferred conformations (4A and 4B, rotated 180° around the Ar-NH bond) 
when docked into the ubiquinone co-factor channel of PfDHODH. 
 
For both molecules 2e and 3e the polar ‘head group’ of the molecule is predicted to bind in the 
polar region of the binding site. Both isomers of each molecule can adopt two distinct hydrogen 
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bonding networks (Figures 4A and 4B). This is again due to a rotation of 180° around Ar-NH bond 
causing the polar ‘head’ of the molecule to flip. Although this ‘flipping’ forces a change in the 
hydrogen bonds made by the molecule and the enzyme, the residues involved in binding in PfDHODH 
are preserved, i.e. histidine185 (H185), tyrosine528 (Y528) and arginine265 (R265). All suggested binding 
poses have hydrogen bonds to at least two of these residues. The results from the docking studies 
suggest that the ligands may bind with multiple poses to the ubquinone channel and that there is no 
clear preference for any one arrangement.  
 
In conclusion, we have discovered two new derivatives (2e and 3e) that are potent inhibitors 
of PfDHODH. 1H and 13C NMR spectroscopic data revealed that these compounds undergo ready 
isomerisation at room temperature in d6-DMSO, but the docking studies indicate that there is neither 
conformation nor configuration which binds preferentially to PfDHODH. This flexibility is favourable 
for inhibitors of this channel that require extensive positioning to reach their binding site. X-ray 
crystallographic study of the red crystal form of (Z)-2e reveals shortened N2-C15 and lengthened C15-
C16 bonds. The delocalisation of the charge onto the nitro group must promote the hydrogen bonding 
interactions between the nitro group and the N9-H, but also with any H-bond donor group on the 
enzyme. This is consistent with the observations made by Phillips and co-workers where an intrinsic 
dipole contribution9b in their triazolopyrimidine class of compounds is also believed to add to the 
hydrogen bonding and thus binding of the inhibitors to the enzyme. Overall, these results further add 
to the knowledge of inhibitor binding to the co-factor binding site of PfDHODH and may assist in the 
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mixture of geometric isomers, both chemical shifts are given when clearly resolved.  11.52 
[11.24] (1H, bd, J ~14.5 [~14.7] Hz, =CH-NH), 9.21 [8.66] (1H, d, J 14.5 [14.7] Hz, =CH-NH), 
8.12-8.09 (1H, m, ArH), 7.95 (1H, dd, J 8.8, 2.2 Hz ArH), 7.57-7.52 (1H, m, ArH), 7.47-7.43 
(2H, m, ArH), 7.37-7.28 (2H, m, ArH), 4.45 (2H, q, J 7.1 Hz, OCH2 or NCH2), 4.42-4.36 (2H, 
m, NCH2 or OCH2), 1.48-1.43 (3H, m, CH2CH3), 1.41 (3H, t, J 7.1 Hz, CH2CH3); 13C-NMR 
(CDCl3, 100 MHz)  164.99 [161.48], 149.82 [146.00], 140.73 [140.70], 138.60 [138.37], 
130.07 [129.88], 126.86 [126.77], 123.74 [123.72], 122.09 [122.06], 120.71, 119.53 [119.45], 
118.28 [117.38], 117.00 [116.69], 110.60 [110.06], 109.58 [109.54], 108.99 [108.94], 61.52 
[61.35], 37.79 [37.76], 14.37 [14.28], 13.78; MS (ESI) m/z 354.1449, [C19H19N3O4+H]+ requires 
354.1448. Also observed were 724.3085 (M2NH4+, calc. 724.3089) and 1077.4459 (M3NH4+, 
calc. 1077.4465); Anal. (C19H19N3O4) Found: C, 64.74 %; H, 6.41 %; N, 11.70 %. Calcd. C, 
64.58 %; H, 5.42 %; N, 11.89 %. In a similar fashion (E/Z)-ethyl 3-(dibenzothiophen-2'-
ylaminomethylene)-2-nitroacrylate (3e) was prepared from ethyl nitroacetate (0.45 g, 7.5 mol) 
and 3-aminodibenzothiophene (0.5 g, 2.5 mol) to give the title compound as a lemon yellow, 
crystalline solid (0.61 g, 71%). 1H NMR (CDCl3, 400 MHz)  11.37 [11.18] (1H, bd, J ~14.3 
[~14.3] Hz, =CH-NH), 9.22 [8.68] (1H, d, J 14.3 [14.3] Hz, =CH-NH), 8.20-8.16 (1H, m, ArH), 
7.99 (1H, dd, J 8.5, 2.4 Hz ArH), 7.93 (1H, d, J 8.5 Hz, ArH), 7.91-7.86 (2H, m, ArH), 7.56-
7.51 (2H, m, ArH), 7.39-7.33 (1H, m, ArH), 4.46 [4.39] (2H, q, J 7.2 Hz, OCH2), 1.45 [1.41] 
(3H, t, J 7.2 Hz, CH2CH3); 13C-NMR (d6-DMSO, 100 MHz, at 24.1 °C) 139.5, 136.6, 136.1, 
136.0, 134.6, 127.6, 124.9, 123.9, 123.2, 122.4, 119.3, 112.5 (broad), 60.8, 14.2; MS (EI) m/z 
342 (M+), 326, 252, 235, 222, 183, 139; Anal. (C17H14N2O4S) Found: C, 59.48 %; H, 4.25 %; N, 
8.20%. Calcd. C, 59.64 %; H, 4.12 %; N, 8.18 %. 
16.  Reaction of o-toluidine with 6a gave a product with an NMR indicating a 1:9 ratio of doubled 
signals [δ 7.45 ppm vs 10.89 ppm for the NH, and δ 8.36 ppm vs 7.87 ppm for the CH]. This 
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however is due to the presence of rotamers about the N-Ar bond due to the ortho methyl group. 
Crystallization of this derivative is induced by cooling a hexane solution, rather than dissolution 
in boiling ethanol, as used for 2f and 3f. The heat presumably encourages any interconversion 
of isomers in the latter case. 
17.  CCDC 857094 contains the supplementary crystallographic data for the red crystalline form of 
(Z)-2e at 150 K. These data can be obtained free of charge from the Cambridge Crystallographic 
Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-336-033; e-mail: 
deposit@ccdc.cam.ac.uk or via http://www.ccdc.cam.ac.uk/conts/retrieving.html. 
18.  CCDC 1550062 contains the supplementary crystallographic data for the orange crystalline form 
of 2e at 150 K. These data can be obtained free of charge from the Cambridge Crystallographic 
Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-336-033; e-mail: 
deposit@ccdc.cam.ac.uk or via http://www.ccdc.cam.ac.uk/conts/retrieving.html. 
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Table S1.  Crystal data and structure refinement for (Z)-2e (red crystals) 
 
Identification code  shelx 
Empirical formula  C19 H19 N3 O4 
Formula weight  353.38 
Temperature  120(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 8.7617(18) Å = 87.020(16)°. 
 b = 8.8742(18) Å = 71.107(15)°. 
 c = 12.804(2) Å  = 61.257(14)°. 
Volume 819.4(3) Å3 
Z 2 
Density (calculated) 1.432 Mg/m3 
Absorption coefficient 0.102 mm-1 
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F(000) 372 
Crystal size 0.120 × 0.120 × 0.030 mm3 
Theta range for data collection 2.638 to 30.043°. 
Index ranges -12 ≤ h ≤ 11, -12 ≤ k ≤ 10, -18 ≤ l ≤ 18 
Reflections collected 8275 
Independent reflections 4779 [R(int) = 0.0513] 
Completeness to theta = 25.242° 99.3 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4779 / 0 / 237 
Goodness-of-fit on F2 1.002 
Final R indices [I>2sigma(I)] R1 = 0.0464, wR2 = 0.1215 
R indices (all data) R1 = 0.0759, wR2 = 0.1371 
Extinction coefficient none 
Largest diff. peak and hole 0.270 and -0.306 e.Å-3 
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Table S2.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for (Z)-2e (red crystals). U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
N(1) 7438(2) 6270(2) -1928(1) 24(1) 
C(1) 8896(2) 4945(2) -2738(1) 22(1) 
C(2) 8862(2) 4116(2) -3623(1) 26(1) 
C(3) 10529(2) 2771(2) -4302(1) 28(1) 
C(4) 12188(2) 2266(2) -4112(1) 27(1) 
C(5) 12237(2) 3108(2) -3250(1) 24(1) 
C(6) 10572(2) 4477(2) -2558(1) 21(1) 
C(7) 10097(2) 5634(2) -1616(1) 21(1) 
C(8) 11136(2) 5839(2) -1063(1) 21(1) 
C(9) 10213(2) 7101(2) -153(1) 21(1) 
C(10) 8273(2) 8115(2) 239(1) 24(1) 
C(11) 7232(2) 7927(2) -311(1) 24(1) 
C(12) 8153(2) 6709(2) -1251(1) 22(1) 
C(13) 5534(2) 7207(2) -1910(1) 25(1) 
C(14) 5256(2) 8549(2) -2716(1) 30(1) 
N(2) 11312(2) 7266(2) 396(1) 23(1) 
C(15) 10713(2) 8497(2) 1200(1) 22(1) 
C(16) 11643(2) 8680(2) 1840(1) 23(1) 
N(3) 13491(2) 7423(2) 1680(1) 25(1) 
O(1) 14338(1) 6288(1) 846(1) 28(1) 
O(2) 14255(2) 7403(2) 2341(1) 42(1) 
C(17) 10680(2) 10153(2) 2731(1) 24(1) 
O(3) 8879(1) 11120(1) 2822(1) 26(1) 
O(4) 11362(2) 10485(2) 3297(1) 35(1) 
C(18) 7786(2) 12655(2) 3641(1) 28(1) 
C(19) 6932(2) 12254(2) 4761(1) 33(1) 
________________________________________________________________________________
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Table S3.   Bond lengths [Å] and angles [°] for (Z)-2e (red crystals). 
_____________________________________________________ 
N(1)-C(1)  1.3840(18) 
N(1)-C(12)  1.3841(17) 
N(1)-C(13)  1.4549(18) 
C(1)-C(2)  1.3975(19) 
C(1)-C(6)  1.4161(19) 
C(2)-C(3)  1.387(2) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.402(2) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.3872(19) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.3996(19) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.4407(18) 
C(7)-C(8)  1.3973(18) 
C(7)-C(12)  1.4133(19) 
C(8)-C(9)  1.3858(19) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.4052(19) 
C(9)-N(2)  1.4242(17) 
C(10)-C(11)  1.3884(19) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.3919(19) 
C(11)-H(11)  0.9500 
C(13)-C(14)  1.516(2) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
N(2)-C(15)  1.3201(17) 
N(2)-H(2A)  0.8800 
C(15)-C(16)  1.3914(18) 
C(15)-H(15)  0.9500 
C(16)-N(3)  1.4071(19) 
C(16)-C(17)  1.4812(19) 
N(3)-O(2)  1.2326(16) 
N(3)-O(1)  1.2592(16) 
C(17)-O(4)  1.2007(17) 
C(17)-O(3)  1.3526(18) 
O(3)-C(18)  1.4547(17) 
C(18)-C(19)  1.501(2) 
C(18)-H(18A)  0.9900 
C(18)-H(18B)  0.9900 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 



















































































Symmetry transformations used to generate equivalent atoms:  
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Table S4.   Anisotropic displacement parameters (Å2x 103) for (Z)-2e (red crystals). The anisotropic 
displacement factor exponent takes the form: -22[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
N(1) 20(1)  26(1) 26(1)  0(1) -11(1)  -10(1) 
C(1) 23(1)  23(1) 23(1)  3(1) -10(1)  -12(1) 
C(2) 29(1)  29(1) 27(1)  4(1) -14(1)  -16(1) 
C(3) 33(1)  29(1) 25(1)  1(1) -12(1)  -17(1) 
C(4) 27(1)  26(1) 25(1)  -2(1) -7(1)  -12(1) 
C(5) 22(1)  25(1) 23(1)  0(1) -7(1)  -11(1) 
C(6) 22(1)  23(1) 22(1)  2(1) -9(1)  -13(1) 
C(7) 21(1)  22(1) 21(1)  3(1) -8(1)  -11(1) 
C(8) 20(1)  22(1) 22(1)  2(1) -8(1)  -10(1) 
C(9) 23(1)  23(1) 21(1)  2(1) -10(1)  -12(1) 
C(10) 23(1)  23(1) 24(1)  -1(1) -8(1)  -10(1) 
C(11) 19(1)  23(1) 27(1)  -1(1) -8(1)  -8(1) 
C(12) 21(1)  23(1) 23(1)  3(1) -10(1)  -11(1) 
C(13) 21(1)  30(1) 29(1)  2(1) -12(1)  -13(1) 
C(14) 23(1)  34(1) 31(1)  5(1) -12(1)  -12(1) 
N(2) 22(1)  25(1) 22(1)  1(1) -8(1)  -12(1) 
C(15) 24(1)  24(1) 22(1)  2(1) -9(1)  -13(1) 
C(16) 23(1)  27(1) 22(1)  1(1) -8(1)  -14(1) 
N(3) 22(1)  31(1) 23(1)  -1(1) -8(1)  -14(1) 
O(1) 23(1)  31(1) 28(1)  -6(1) -7(1)  -11(1) 
O(2) 27(1)  54(1) 39(1)  -13(1) -18(1)  -10(1) 
C(17) 24(1)  29(1) 22(1)  1(1) -7(1)  -15(1) 
O(3) 25(1)  28(1) 26(1)  -4(1) -8(1)  -12(1) 
O(4) 31(1)  42(1) 33(1)  -9(1) -12(1)  -18(1) 
C(18) 29(1)  25(1) 27(1)  -2(1) -8(1)  -11(1) 
C(19) 34(1)  36(1) 29(1)  -2(1) -5(1)  -20(1) 
______________________________________________________________________________
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Table S5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for (Z)-2e (red crystals). 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(2) 7739 4461 -3754 31 
H(3) 10547 2181 -4907 33 
H(4) 13304 1325 -4583 32 
H(5) 13370 2765 -3133 28 
H(8) 12444 5131 -1306 25 
H(10) 7668 8934 885 29 
H(11) 5921 8616 -51 29 
H(13A) 4702 7788 -1148 30 
H(13B) 5193 6373 -2104 30 
H(14A) 6101 7983 -3469 45 
H(14B) 5512 9422 -2497 45 
H(14C) 3974 9109 -2702 45 
H(2A) 12493 6480 181 34 
H(15) 9464 9389 1365 27 
H(18A) 6795 13559 3392 34 
H(18B) 8588 13116 3699 34 
H(19A) 7913 11433 5037 50 
H(19B) 6188 11743 4697 50 
H(19C) 6138 13324 5282 50 
________________________________________________________________________________ 
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CCDC 1550062 contains the supplementary crystallographic data for the orange crystalline form 
of 2e at 150 K. These data can be obtained free of charge from the Cambridge Crystallographic 
Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-336-033; e-mail: 




Table S6.  Crystal data and structure refinement for 2e (orange crystal). 
 
Identification code  shelx 
Empirical formula  C19 H19 N3 O4 
Formula weight  353.37 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 8.123(2) Å = 91.517(16)°. 
 b = 8.2709(17) Å = 102.586(18)°. 
 c = 13.834(3) Å  = 110.110(18)°. 
Volume 846.6(3) Å3 
Z 2 
Density (calculated) 1.386 Mg/m3 
©2018, Elsevier. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Absorption coefficient 0.099 mm-1 
F(000) 372 
Crystal size 0.230 × 0.140 × 0.030 mm3 
Theta range for data collection 2.639 to 25.701°. 
Index ranges -9 ≤ h ≤ 9, -10 ≤ k ≤ 9, -16 ≤ l ≤ 16 
Reflections collected 7363 
Independent reflections 3202 [R(int) = 0.1891] 
Completeness to theta = 25.242° 99.9 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3202 / 0 / 235 
Goodness-of-fit on F2 1.020 
Final R indices [I>2sigma(I)] R1 = 0.1037, wR2 = 0.2756 
R indices (all data) R1 = 0.2014, wR2 = 0.3482 
Extinction coefficient none 
Largest diff. peak and hole 1.169 and -0.357 e.Å-3 
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Table S7.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) for 2e (orange 
crystal).  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 4044(9) 3717(7) 8594(4) 60(2) 
C(2) 3184(9) 3231(8) 9377(4) 60(2) 
C(3) 1912(10) 3928(8) 9483(5) 66(2) 
C(4) 1465(10) 5088(8) 8850(5) 69(2) 
C(5) 2313(11) 5554(8) 8088(5) 71(2) 
C(6) 3625(10) 4912(7) 7950(4) 63(2) 
C(7) 4804(10) 5180(8) 7279(4) 68(2) 
C(8) 5062(12) 6246(8) 6525(5) 80(2) 
C(9) 6317(13) 6298(9) 6041(5) 88(3) 
C(10) 7348(11) 5213(10) 6243(5) 87(3) 
C(11) 7137(10) 4070(9) 7010(5) 77(2) 
C(12) 5845(9) 4104(8) 7528(4) 65(2) 
C(13) 6129(9) 2028(7) 8823(4) 60(2) 
C(14) 4969(9) 156(8) 8461(5) 70(2) 
C(15) 7619(12) 7819(11) 4745(6) 92(3) 
C(16) 8059(10) 9077(8) 4119(5) 71(2) 
C(17) 9406(10) 8984(8) 3578(5) 69(2) 
C(18) 10848(10) 9885(9) 2286(5) 72(2) 
C(19) 10808(10) 11087(9) 1503(5) 76(2) 
N(1) 5383(7) 3255(6) 8321(3) 60(1) 
N(2) 6573(10) 7578(8) 5295(5) 89(2) 
N(3) 7390(9) 10469(7) 4063(4) 68(2) 
O(1) 5949(9) 10215(6) 4311(4) 95(2) 
O(2) 8247(6) 11864(5) 3796(3) 70(1) 
O(3) 9595(6) 10009(5) 2866(3) 67(1) 
O(4) 10210(8) 7986(6) 3765(4) 89(2) 
________________________________________________________________________________
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Table S8.   Bond lengths [Å] and angles [°] for 2e (orange crystal). 
_____________________________________________________ 
C(1)-N(1)  1.388(9) 
C(1)-C(2)  1.409(9) 
C(1)-C(6)  1.426(9) 
C(2)-C(3)  1.375(10) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.402(9) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.375(10) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.388(10) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.442(10) 
C(7)-C(8)  1.388(9) 
C(7)-C(12)  1.426(10) 
C(8)-C(9)  1.326(12) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.419(13) 
C(9)-N(2)  1.493(10) 
C(10)-C(11)  1.439(11) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.401(10) 
C(11)-H(11)  0.9500 
C(12)-N(1)  1.370(8) 
C(13)-N(1)  1.468(8) 
C(13)-C(14)  1.512(8) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(15)-N(2)  1.229(10) 
C(15)-C(16)  1.374(10) 
C(15)-H(15)  0.9500 
C(16)-N(3)  1.430(9) 
C(16)-C(17)  1.474(11) 
C(17)-O(4)  1.218(8) 
C(17)-O(3)  1.316(8) 
C(18)-O(3)  1.454(8) 
C(18)-C(19)  1.492(10) 
C(18)-H(18A)  0.9900 
C(18)-H(18B)  0.9900 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 
C(19)-H(19C)  0.9800 
N(2)-H(2A)  0.8800 
N(3)-O(2)  1.239(6) 
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_____________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
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Table S9.   Anisotropic displacement parameters (Å2x 103)for 2e (orange crystal). The anisotropic displacement 
factor exponent takes the form: -22[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 70(4)  39(3) 52(3)  -1(3) 5(3)  2(3) 
C(2) 70(4)  48(3) 46(3)  5(3) 6(3)  4(3) 
C(3) 72(4)  55(3) 57(3)  -4(3) 15(3)  8(3) 
C(4) 88(5)  53(3) 57(4)  -3(3) 7(4)  22(3) 
C(5) 93(5)  40(3) 58(4)  -6(3) -6(4)  13(3) 
C(6) 80(5)  37(3) 46(3)  -3(2) -1(3)  0(3) 
C(7) 86(5)  43(3) 45(3)  -4(3) 1(3)  -4(3) 
C(8) 104(6)  44(3) 48(3)  2(3) 6(4)  -20(3) 
C(9) 112(7)  53(4) 52(4)  5(3) 5(4)  -19(4) 
C(10) 83(5)  79(5) 59(4)  -15(4) 23(4)  -23(4) 
C(11) 76(5)  72(4) 54(4)  -8(3) 15(3)  -6(3) 
C(12) 70(4)  49(3) 48(3)  -1(3) 6(3)  -7(3) 
C(13) 62(4)  51(3) 54(3)  5(3) 6(3)  10(3) 
C(14) 66(4)  51(3) 74(4)  5(3) 6(3)  5(3) 
C(15) 91(6)  78(5) 61(4)  -17(4) 4(4)  -16(4) 
C(16) 95(5)  42(3) 46(3)  8(3) -3(3)  -2(3) 
C(17) 78(5)  46(3) 56(4)  -7(3) -6(3)  3(3) 
C(18) 72(5)  61(4) 72(4)  -18(3) 12(4)  17(3) 
C(19) 79(5)  77(4) 63(4)  -6(4) 18(4)  15(4) 
N(1) 69(3)  45(2) 49(3)  10(2) 7(2)  3(2) 
N(2) 90(5)  74(4) 72(4)  -13(3) 12(4)  -4(3) 
N(3) 88(4)  49(3) 52(3)  -2(2) 20(3)  4(3) 
O(1) 116(5)  67(3) 108(4)  8(3) 68(4)  17(3) 
O(2) 85(3)  48(2) 64(3)  11(2) 20(2)  8(2) 
O(3) 75(3)  49(2) 61(2)  3(2) 6(2)  10(2) 
O(4) 110(4)  62(3) 74(3)  -5(2) -13(3)  28(3) 
______________________________________________________________________________
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Table S10.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for 2e (orange 
crystal). 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(2) 3471 2450 9816 72 
H(3) 1314 3610 10006 79 
H(4) 583 5548 8947 83 
H(5) 1998 6325 7651 85 
H(8) 4341 6938 6356 96 
H(10) 8199 5242 5862 104 
H(11) 7825 3344 7154 92 
H(13A) 6259 2227 9549 72 
H(13B) 7349 2255 8712 72 
H(14A) 5530 -601 8821 105 
H(14B) 3767 -87 8583 105 
H(14C) 4857 -59 7746 105 
H(15) 8216 7011 4756 110 
H(18A) 10478 8683 1975 86 
H(18B) 12083 10222 2719 86 
H(19A) 11640 11040 1095 114 
H(19B) 9580 10740 1079 114 
H(19C) 11177 12272 1821 114 
H(2A) 5905 8228 5242 107 
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A portion of the orange powder, obtained from the mother liquors of the crystallisation of red 
(Z)-2e, was examined by X-ray powder diffraction using a PANAlytical Empyrean 
diffractometer operating with Cu Kα1 radiation. The powder was shown to be highly 
crystalline, but the diffraction pattern of the orange powder did not match that calculated from 
the structure of the red crystals (Figure S2) or orange crystals obtained (Figure S3). It was 
possible to index the powder diffraction pattern of the orange powder using a large triclinic cell 
with parameters shown below. The volume of this cell (2506 Å3) is approximately three times 
that of the cell found for the red crystals. It seems reasonable that the orange sample contains 
(E)-2e and the tripling of the volume suggests that there are three molecules in the asymmetric 
unit, perhaps two of one isomeric form and one of the other.  
a = 15.93(3) Å 
b = 15.03(3) Å 
c = 13.07(3) Å 
α = 70.08(17) ° 
β = 106.64(14) ° 
γ = 120.70(16) ° 
 
Figure S1: Powder X-ray diffraction pattern of the orange powder of 2e, and calculated 
pattern of the red crystals of 2e. 
 






Figure S2: Overlay of the structures of the red and orange crystalline forms of 2e. 
 
Figure S3: Powder X-ray diffraction pattern of the orange powder of 2e, and calculated 
pattern of the orange crystals of 2e. 
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